Marker Therapeutics (MRKR) is a clinical-stage immuno-oncology Company with the worldwide exclusive license of Multi-Antigen Targeted T cells, a ...

Clinical study from Baylor College of Medicine demonstrates a favorable safety profile and up to 84.6% disease control rate in patients with ...

Final results from first pancreatic cancer study in Montreal demonstrate 81% disease control rate, or 87% excluding the first ...

Cancer is an umbrella term used to characterize the abnormal growth of cells in different organs and tissues. Specific cancer types are named and categorized commonly based on location, mutation, and ...

BullFrog AI's bfLEAP platform identified biomarkers linked to improved survival in pancreatic adenocarcinoma patients treated ...

When the doctor utters the word “cancer” one might immediately go numb as their mind takes a minute to comprehend the severity of the diagnosis. The next question that usually comes to mind is, “what ...

A 69 year old female patient with cancer in the head (widest part) of the pancreas spreading to a major abdominal artery (left image). After combined chemotherapy and radiation treatment, the tumor ...